Admission C‐Reactive Protein–Albumin–Lymphocyte Index and Risk Stratification for Contrast‐Associated Acute Kidney Injury in ST‐Segment Elevation Myocardial Infarction: Comparison With the Systemic Immune‐Inflammation Index
Catheterization and Cardiovascular Interventions · 19.11.2026
DOI: 10.1002/ccd.71022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 19.11.2026. Verfasst von Funda Özlem Pamuk und 7 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Many blood‐based inflammatory and nutritional indices have been linked to contrast‐associated acute kidney injury (CA‐AKI) after primary percutaneous coronary intervention (PCI) for ST‐segment elevation myocardial infarction (STEMI), but they are rarely compared with one another or tested for what they add to existing risk models. The C‐reactive protein–albumin–lymphocyte (CALLY) index and the systemic immune‐inflammation index (SII) both come from routine admission blood tests, yet no study has compared them directly for CA‐AKI or asked whether CALLY adds anything to a standard clinical model.
Aims
We tested whether CALLY predicts CA‐AKI independently of SII in STEMI, and whether it improves reclassification and net benefit on top of a full clinical model.
Methods
In this retrospective cohort study, we reviewed 1561 consecutive STEMI patients treated with primary PCI between 2021 and 2025. CA‐AKI was defined by the KDIGO 48‐h criterion (creatinine rise ≥ 0.3 mg/dL), with creatinine measured daily in every patient. CALLY and ln(SII) were added, alone and together, to a prespecified clinical risk model. Models were compared with the DeLong test, continuous NRI, IDI, and decision‐curve analysis.
Results
CA‐AKI developed in 317 patients (20.3%). CALLY discriminated CA‐AKI better than ln(SII) (AUC 0.632 vs. 0.559; DeLong p = 0.0003). When both were entered together, CALLY stayed independent (OR 0.872, 95% CI 0.783–0.970; p = 0.012), but ln(SII) did not ( p = 0.145), even though SII was independent on its own. Adding CALLY produced only a small change in the C‐statistic (0.752–0.762; DeLong non‐significant), yet it improved reclassification (IDI 0.007, p = 0.003; NRI 0.166, p = 0.005) and net benefit, and calibration remained adequate (Hosmer–Lemeshow p ≥ 0.249).
Conclusion
In STEMI patients undergoing primary PCI, a low CALLY index was independently associated with CA‐AKI and improved risk reclassification when added to a clinical model, whereas SII was not independent once CALLY was included. This is the first comparison of CALLY and SII for CA‐AKI, and the first assessment of CALLY for CA‐AKI in STEMI.
Zitieren
APA
Pamuk, F. Ö., Dönmez, E., İnan, D., Albayrak, D. G., Erdem, B., Alp, E., Şahin, V. C., & Püşüroğlu, H. (2026). Admission C‐Reactive Protein–Albumin–Lymphocyte Index and Risk Stratification for Contrast‐Associated Acute Kidney Injury in ST‐Segment Elevation Myocardial Infarction: Comparison With the Systemic Immune‐Inflammation Index. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.71022
Vancouver
Pamuk FÖ, Dönmez E, İnan D, Albayrak DG, Erdem B, Alp E, et al. Admission C‐Reactive Protein–Albumin–Lymphocyte Index and Risk Stratification for Contrast‐Associated Acute Kidney Injury in ST‐Segment Elevation Myocardial Infarction: Comparison With the Systemic Immune‐Inflammation Index. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.71022
BibTeX
@article{Pamuk2026,
author = {Pamuk, Funda Özlem and Dönmez, Esra and İnan, Duygu and Albayrak, Duygu Genç and Erdem, Berat and Alp, Ezgi and Şahin, Volkan Can and Püşüroğlu, Hamdi},
title = {Admission C‐Reactive Protein–Albumin–Lymphocyte Index and Risk Stratification for Contrast‐Associated Acute Kidney Injury in ST‐Segment Elevation Myocardial Infarction: Comparison With the Systemic Immune‐Inflammation Index},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.71022}
}
EUVIMED